Recruiting Pulmonary Embolism Studies in Phialdelphia
About Pulmonary Embolism Clinical Trials in Phialdelphia
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 1 pulmonary embolism clinical trials recruiting participants in Phialdelphia, PA. These studies are seeking a combined 2,300 participants. Research is being sponsored by University of Pennsylvania. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Phialdelphia — FAQ
Are there pulmonary embolism clinical trials in Phialdelphia?
Yes, there are 1 pulmonary embolism clinical trials currently recruiting in Phialdelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Phialdelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phialdelphia research site will contact you about next steps.
Are clinical trials in Phialdelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phialdelphia studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 1 active trials in Phialdelphia are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated October 20, 2026 from ClinicalTrials.gov